Detalhe da pesquisa
1.
Pregnancy outcomes for women with myasthenia gravis and their newborns: A nationwide register-based cohort study.
Eur J Neurol
; 31(1): e16100, 2024 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37843262
2.
Presence of neural surface and onconeural autoantibodies in cerebrospinal fluid and serum in neurological diseases presents a potential risk for misdiagnosis.
Eur J Neurol
; 30(9): 2602-2610, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37312655
3.
The impact of hybrid immunity on immune responses after SARS-CoV-2 vaccination in persons with multiple sclerosis treated with disease-modifying therapies.
Eur J Neurol
; 30(12): 3789-3798, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37522464
4.
Inflammation-related plasma and CSF biomarkers for multiple sclerosis.
Proc Natl Acad Sci U S A
; 117(23): 12952-12960, 2020 06 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32457139
5.
No increase of serum neurofilament light in relapsing-remitting multiple sclerosis patients switching from standard to extended-interval dosing of natalizumab.
Mult Scler
; 28(13): 2070-2080, 2022 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-35856574
6.
Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing-remitting multiple sclerosis: an observational study.
J Neurol Neurosurg Psychiatry
; 92(2): 189-194, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33106366
7.
Ultrasensitive DNA Immune Repertoire Sequencing Using Unique Molecular Identifiers.
Clin Chem
; 66(9): 1228-1237, 2020 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32814950
8.
Cerebrospinal fluid CD4+ /CD8+ ratio in diagnosing neurosarcoidosis.
Acta Neurol Scand
; 142(5): 480-485, 2020 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-32533774
9.
Intrathecal immunoreactivity in people with or without previous infectious mononucleosis.
Acta Neurol Scand
; 142(2): 161-168, 2020 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-32415852
10.
Cerebrospinal fluid NCAM levels are modulated by disease-modifying therapies.
Acta Neurol Scand
; 139(5): 422-427, 2019 May.
Artigo
Inglês
| MEDLINE | ID: mdl-30657162
11.
Sulfatide isoform pattern in cerebrospinal fluid discriminates progressive MS from relapsing-remitting MS.
J Neurochem
; 146(3): 322-332, 2018 08.
Artigo
Inglês
| MEDLINE | ID: mdl-29676479
12.
Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis.
J Neurochem
; 141(2): 296-304, 2017 04.
Artigo
Inglês
| MEDLINE | ID: mdl-27787906
13.
Rituximab versus fingolimod after natalizumab in multiple sclerosis patients.
Ann Neurol
; 79(6): 950-8, 2016 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-27038238
14.
Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis.
Mult Scler
; 23(1): 62-71, 2017 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27003946
15.
Soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantrone.
Mult Scler
; 22(12): 1587-1595, 2016 10.
Artigo
Inglês
| MEDLINE | ID: mdl-26754805
16.
Upper Respiratory Infections and MRI Activity in Relapsing-Remitting Multiple Sclerosis.
Neuroepidemiology
; 45(2): 83-9, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26316226
17.
Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis.
Mult Scler
; 20(1): 43-50, 2014 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-23702432
18.
Association of serum glial fibrillary acidic protein with progression independent of relapse activity in multiple sclerosis.
J Neurol
; 2024 Apr 26.
Artigo
Inglês
| MEDLINE | ID: mdl-38668889
19.
MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS).
BMC Immunol
; 14: 32, 2013 Jul 29.
Artigo
Inglês
| MEDLINE | ID: mdl-23895517
20.
Cerebrospinal fluid biomarkers of ß-amyloid metabolism in multiple sclerosis.
Mult Scler
; 19(5): 543-52, 2013 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-23069872